$169 Million is the total value of Tamarack Advisers, LP's 38 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | NOVOCURE LTDequity | $15,657,000 | +95.1% | 905,000 | -8.7% | 9.14% | +82.3% | |
| PCRX | Sell | PACIRA PHARMACEUTICALS INCequity | $10,256,000 | -15.1% | 215,000 | -18.9% | 5.99% | -20.7% |
| SPNC | Sell | SPECTRANETICS CORPequity | $10,176,000 | +16.5% | 265,000 | -11.7% | 5.94% | +8.8% |
| GILD | Sell | GILEAD SCIENCES INCequity | $9,555,000 | -6.2% | 135,000 | -10.0% | 5.58% | -12.4% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLCequity | $8,553,000 | +3.4% | 55,000 | -3.5% | 4.99% | -3.4% |
| CRME | Sell | CARDIOME PHARMA CORPequity | $8,136,000 | +48.1% | 1,800,000 | -1.4% | 4.75% | +38.4% |
| CORI | Sell | CORIUM INTERNATIONAL INCequity | $7,274,000 | +63.7% | 975,000 | -8.3% | 4.25% | +53.0% |
| STE | Sell | STERIS PLCequity | $6,928,000 | +1.6% | 85,000 | -13.4% | 4.04% | -5.0% |
| OBLN | Sell | OBALON THERAPEUTICS INCequity | $5,233,000 | -13.5% | 528,066 | -6.7% | 3.06% | -19.2% |
| BKD | Sell | BROOKDALE SENIOR LIVING INCequity | $4,781,000 | -29.7% | 325,000 | -35.4% | 2.79% | -34.4% |
| HCA | Sell | HCA HEALTHCARE INCequity | $4,360,000 | -38.8% | 50,000 | -37.5% | 2.54% | -42.8% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INCequity | $3,916,000 | -47.6% | 50,000 | -44.4% | 2.29% | -51.0% |
| ALKS | Sell | ALKERMES PLCequity | $1,739,000 | -62.8% | 30,000 | -62.5% | 1.02% | -65.3% |
| RCM | Sell | R1 RCM INCequity | $938,000 | +18.0% | 250,000 | -2.9% | 0.55% | +10.3% |
| AMGN | Exit | AMGN US 04/21/17 C175listed option | $0 | – | -130 | -100.0% | -0.00% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -50,000 | -100.0% | -0.22% | – |
| ENTL | Exit | ENTELLUS MEDICAL INC | $0 | – | -45,837 | -100.0% | -0.40% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -17,100 | -100.0% | -1.00% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -70,969 | -100.0% | -1.07% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -30,000 | -100.0% | -2.11% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -200,000 | -100.0% | -3.11% | – |
| TDOC | Exit | TELADOC INC | $0 | – | -305,000 | -100.0% | -4.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.